姜虎林
个人信息Personal Information
教授
博士生导师
教师英文名称:Hu-Lin Jiang
教师拼音名称:Jiang Hulin
电子邮箱:
入职时间:2004-09-01
所在单位:药剂系
学历:博士研究生毕业
办公地点:中国药科大学江宁校区学院实验楼1期
性别:男
在职信息:在岗
毕业院校:首尔大学(韩国)
学科:药剂学
- A pro-metastatic derivatives eliminator for in vivo dual-removal of circulating tumor cells and tumor-derived exosomes impedes their biodistribution into distant organs:Advanced Science,2023
- Progress on the pathological tissue microenvironment barrier-modulated nanomedicine:Advanced Drug Delivery Reviews,2023
- Nanoengineered-mesenchymal stem cell therapy for pulmonary fibrosis in young and aged mice:Science Advances,2023
- Tumor microenvironment-initiated lipid redox cycling for efficient triple-negative breast cancer therapy:Biomaterials,2023
- A novel whole blood purifier for efficient capture and separation of circulating tumor cells:Biosensors & Bioelectronics,2023
- Response letter to Sun et al, re: Pathological collagen targeting and penetrating liposomes for idiopathic pulmonary fibrosis therapy:Journal of Controlled Release,2023
- Remodeling of imbalanced extracellular matrix homeostasis for reversal of pancreatic fibrosis:Biomaterials,2022
- Pathological collagen targeting and penetrating liposomes for idiopathic pulmonary fibrosis therapy:Journal of Controlled Release,2022
- Enhanced nuclear gene delivery via integrating and streamlining intracellular pathway:Journal of Controlled Release,2022
- Sequential nano-penetrators of capillarized liver sinusoids and extracellular matrix barriers for liver fibrosis therapy:ACS Nano,2022
- Photothermal nanozyme-ignited Fenton reaction-independent ferroptosis for breast cancer therapy:Journal of Controlled Release,2021
- Gene therapy strategies for rare monogenic disorders with nuclear or mitochondrial gene mutations:Biomaterials,2021
- Pathologically responsive mitochondrial gene therapy in an allotopic expression-independent manner cures Leber's hereditary optic neuropathy:Advanced Materials,2021
- A harmless-harmful switchable and uninterrupted laccase-instructed killer for activatable chemodynamic therapy:Advanced Materials,2021
- A carrier-free anti-inflammatory platinum (II) self-delivered nanoprodrug for enhanced breast cancer therapy:Journal of Controlled Release,2021